Table of Contents

<< Previous Issue

Nov 2008 (Vol: 2008, Issue: 102)

Next Issue >>

Download pdf of entire issue

Section: Business Commentaries
The Rebirth of Regenerative Medicine Published: 25 Nov-2008
By: Fintan Walton
Abstract Fulltext:
Section: Licensing
Genzyme and Osiris Sign Deal for First-in-Class Adult Stem Cell Products Published: 4 Nov-2008
By: Taskin Ahmed
Abstract Fulltext:
Eli Lilly Steps Up Pharmacogenetics Effort Published: 6 Nov-2008
By: Sally Mardikian PhD
Abstract Fulltext:
XOMA Makes Cost-Cutting Move by Restructuring Novartis Deal Published: 10 Nov-2008
By: Helen Scrutton
Abstract Fulltext:
Cash-strapped TorreyPines Divests its Alzheimer’s Disease Developments Published: 18 Nov-2008
By: Taskin Ahmed
Abstract Fulltext:
Merrion to Develop Insulin Drugs with Novo Published: 24 Nov-2008
By: Taskin Ahmed
Abstract Fulltext:
Cephalon Signs Option Agreement for ImmuPharma’s First-in-class Lupus Drug Published: 25 Nov-2008
By: Helen Scrutton
Abstract Fulltext:
Galapagos Diversifies into Antibodies Published: 26 Nov-2008
By: Sally Mardikian PhD
Abstract Fulltext:
Section: Mergers & Acquisitions
Zydus Cadila Enters Vaccines Market by Acquiring Etna Biotech Published: 11 Nov-2008
By: Taskin Ahmed
Abstract Fulltext:
NitroMed and Archemix Sign Reverse Merger Deal Published: 18 Nov-2008
By: Helen Scrutton
Abstract Fulltext:
Johnson & Johnson Strengthens its Biosurgical Position by Acquiring Omrix Published: 24 Nov-2008
By: Sally Mardikian PhD
Abstract Fulltext:

Login

Login

Username:

Password:

Keep me logged in

Login Problems? Subscribe

IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents